insights_auto
Bakit bumaba ang CRSP 2.83%?
Tingnan ang Higit pang Detalyechevron_right
CRSP:NASDAQ
Crispr Therapeutics AG
$50.09
arrow_downward
-2.83%(-1.46) 1D
Okt 13, 12:43:44 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CRSP...
Buksan
$51.01
Mataas
$51.11
Mababa
$49.77
Mkt. cap
4.84B
Avg. na dami
1.62M
Dami
573.71K
Mataas nang 52-wk
$75.06
Mababa nang 52-wk
$44.12
EPS
-$4.76
Beta
1.45
Mga natitirang share
96.69M
Bilang ng mga empleyado
393
Buksan
$51.01
Mataas
$51.11
Mababa
$49.77
Mkt. cap
4.84B
Avg. na dami
1.62M
Dami
573.71K
Mataas nang 52-wk
$75.06
Mababa nang 52-wk
$44.12
EPS
-$4.76
Beta
1.45
Mga natitirang share
96.69M
Bilang ng mga empleyado
393
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Zacks
·
18 oras ang nakalipas
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
Yahoo Finance Australia
·
19 oras ang nakalipas
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
Zacks
·
1 araw ang nakalipas
TEVA Gets FDA Nod for Weltruza as Once-Monthly LAI in Schizophrenia
Zacks
·
1 araw ang nakalipas
Roche Reports Positive Phase III Data on Eye Drug, FDA Accepts BLA
Profile
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
Tungkol sa Crispr Therapeutics AG
CEOSamarth Kulkarni
Mga Empleyado393
Itinatag2013
HeadquartersZug, Zug, Switzerland
Sektor-
Websitecrisprtx.com